An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

New Digital Health Community Delivers Rare Disease Resources and Peer Support for ATTR Amyloidosis Patients and Caregivers PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- Health Union, the leading digital ...

The type of ATTR you have and how early it was diagnosed are two factors that can affect the prognosis of your disease.

Get insights on Biogen’s Leqembi sales outlook, clinical value, risks, and what new drug approvals may mean for investors.

Trontinemab, utilizing Roche’s Brainshuttle technology, boosts drug delivery across the blood-brain barrier, driving robust plaque reduction with low ARIA rates.

One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many ...

AI can detect biological signs of Alzheimer's disease years before symptoms are noted by the patient or their loved ones using only a 3-minute digital assessment delivered in a physician's office. New ...